'n Oorsig geskryf deur Young, MD, Anderson Cancer Center, VSA, het die toepassing van PD-1-remmer-immunoterapie in B-sel limfoom verduidelik. (Bloed. Aanlyn weergawe op 8 November 2017. doi: 10.1182 / bloed-2017-07-740993.)PD-1 immune..
Die Cleveland-kliniek van die Verenigde State Eric D. His et al. Gerapporteer dat die diagnose van perifere T-sel limfoom (PTCL) in die Verenigde State baie verskil, en dikwels nie belangrike fenotipiese inligting het om ten volle te onderskei nie.
Volwasse T-sel gewasse, soos nie-Hodgkin T-sel limfoom, is hoogs indringend en dwelm-weerstandig, en pasiënte het dikwels 'n swak prognose. Onlangs het 'Nature'-reeks van twee artikels 'n nuwe interpretasie van die patogeen gepubliseer.
Obesity not only runs counter to the aesthetics of people, but also causes many chronic diseases. Some studies have shown that body mass index (BMI) is related to the risk of cancer in certain parts (such as the digestive system),..
Yesterday, the US FDA announced the approval of Seattle Genetics' antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with chemotherapy for patients with previously treated stage III or IV classic Hodgkin's lymph..
Nuwe Cleveland Clinic-navorsing toon vir die eerste keer dat FDA-goedgekeurde ibrutinib (ibrutinib) vir limfoom en leukemie ook kan help met die behandeling van die mees algemene en dodelike breingewasse, en kan eendag by pasiënte met gliobla gebruik word.
Bone marrow fibrosis is a rare chronic disease of bone marrow hematopoietic cells. They benefit from JAK2 inhibitor drugs: symptom relief, prolonged survival, and improved quality of life. However, two or three years after starti..
On June 12-13, FDA approved two new indications for K drug, just the day before the K drug was approved for the treatment of cervical cancer. One day later, the US FDA approved pembrolizumab (Keytruda, pembrolizumab) for the trea..
In the United States, more than 70,000 people are diagnosed with non-Hodgkin's lymphoma each year, which is caused by excessive proliferation of immune cells in the body's lymph nodes. The most common is diffuse large B-cell lymp..
In onlangse jare was die effek van immuunkontrolepunt-inhibeerders op die behandeling van Hodgkin se limfoom (HL) indrukwekkend, maar die siekte moet nog deegliker oorkom word. Ansell, voorsitter van die Mayo Clinic se limfoomgroep, sê...